Results 111 to 120 of about 32,470,234 (258)

Serum Immunoglobulin Levels in Iraqi Twins

, 2020
A study of serum immunoglobulin G, A, M and E levels in 107 pairs of Iraqi twins was carried out. The results suggest strong evidence for genetic as well as environ­mental factors in all four immunoglobulin ...
Al-Agidi, Saad K
core   +1 more source

Immunoglobulin E-rheumatoid factor in juvenile rheumatoid arthritis

, 2002
OBJECTIVES: To determine the presence of immunoglobulin E-rheumatoid factor in patients with juvenile rheumatoid arthritis and to correlate it with clinical and laboratory parameters.
Sopelete, Mônica Camargo, Silva, Deise Aparecida Oliveira, Ferreira, Rosa Aparecida, Mineo, José Roberto, Silva, Carlos Henrique Martins, Kiss, Maria Helena Bittencourt, Ferriani, Virgínia Paes Leme   +6 more
core   +1 more source

6th International Immunoglobulin Symposium: poster presentations [PDF]

, 2009
The posters presented at the 6th International Immunoglobulin Symposium covered a wide range of fields and included both basic science and clinical research.
van Schaik, I N, Yuki, Nobuhiro, Winkelmann, A, N. Yuki, A. Durandy, Käsermann, F., Durandy, Anne, Quinti, I., Fernandez-Cruz, E, Durandy, A., Danieli, Maria Giovanna, A. Winkelmann, Cantoni, N, M. G. Danieli, Kaesermann, F., Käsermann, F, Helbert, M., Späth, P, Späth, Paul, J. Bayry, P. Spath, van Schaik, I.N., Fernández-Cruz, Eduardo, QUINTI, Isabella, Quinti, I, Kaveri, S. V., Durandy, A, Bussel, J B, Bayry, J, I. N. Van Schaik, Cantoni, N., J. B. Bussel, Helbert, M, Peter Hh, Bussel, J.B., Winkelmann, A., Spaeth, P., R. Sorensen, Yuki, N, Peter, Hans-Hartmut, Sorensen, R., Schaik, Ivo N. van, M. Helbert, Bayry, J., Yuki, N., Sorensen, R, Kaveri, S V, S. V. Kaveri, Salama, A., E. Fernandez Cruz, Salama, A, A. Salama, Kaveri, S.V., Fernandez-Cruz, E., Peter, H.H., Winkelmann, Aline, Danieli, M.G., Danieli, M G, F. Kasermann, Helbert, Matthew, Peter, H-H, N. Cantoni, Bussel, J. B., Salama, Abdulgabar, Späth, Peter Julius   +64 more
core   +1 more source

Comprehensive Assessment of Arterial, Tissue, and Venous Collaterals for Evaluating the Infarct Growth Rate: The Multimodal Collateral Score

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Collaterals are crucial factors that influence the infarct growth rate (IGR). We aimed to determine whether a comprehensive multimodal collateral score (MCS), incorporating collateral assessment at the arterial, tissue, and venous levels, is associated with functional independence and provides incremental prognostic value over ...
Giorgio Busto, Umberto Pensato, Ilaria Casetta, Giorgio U. Marcello, Angelo Barra, Anna Poggesi, Edoardo Carlesi, Sara Mancini, Andrea Ginestroni, Vittorio Miele, Alessandro Padovani, Andrea Morotti, Enrico Fainardi   +12 more
wiley   +1 more source

Analysis of immunoglobulin E-mediated responses in central Africa

, 2003
Analysis of immunoglobulin E-mediated responses in central ...
Cenk Suphioglu (13063443)
core  

Human normal immunoglobulin in the treatment of primary immunodeficiency diseases [PDF]

, 2012
Philip WoodSt James University Hospital, Leeds, United KingdomAbstract: The primary antibody deficiency syndromes are a rare group of disorders that can present at any age, and for which delay in diagnosis remains common.
Wood P
core  

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin, Binbin Xue, Dewei Xie, Jia Li, Juyuan Pan, Lanbing Zhu, Qiaowen Tong, Jing Lin, Ruofan Zhu, Xu Zhang, Junhui Xia, Xiang Li   +11 more
wiley   +1 more source

Intravenous Immunoglobulin therapy for anti-E hemolytic disease in the newborn.

, 2010
Anti-E alloimmunisation is a less common cause of haemolytic disease in the newborn (HDN) and is usually associated with mild to moderate clinical manifestations, that are often less severe than anti-D immunisation.
Ruggiero, Antonio, Rizzo, Daniela, Onesimo, Roberta, Valentini, Piero, Antonio Ruggiero, Daniela Rizzo, Roberta Onesimo, Piero Valentini   +7 more
core   +1 more source

Long‐Term Efficacy of Immunotherapy in Autoimmune Autonomic Ganglionopathy—A 10‐Year Follow Up Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Autoimmune autonomic ganglionopathy (AAG) is a rare but potentially treatable cause of severe autonomic failure. Evidence guiding long‐term immunotherapy, treatment sequencing, and residual autonomic impairment is limited. We evaluated long‐term treatment response, residual autonomic dysfunction, and relapse patterns in patients with
Giacomo Chiaro, Shiwen Koay, Gordon T. Ingle, Patricia McNamara, Laura Watson, Fion Bremner, Valeria Iodice   +6 more
wiley   +1 more source

In vitro evaluation of biospecific and pseudobiospecific ligands aimed at extracorporeal treatment for immunoglobulin E removal

, 2015
This work investigated the potential use of an alternative adsorbent to anti-immunoglobulin E (IgE)-agarose for IgE selective adsorption therapy. A screening of several commercially available adsorbents (Concanavalin A, Lens culinaris [Lc], D-tryptophan,
Duarte, IS, Zollner, RL, Bueno, SMA
core   +1 more source